ReviewWorld J Gastrointest Oncol2018
Shattering the castle walls: Anti-stromal therapy for pancreatic cancer.
- Journal
- World J Gastrointest Oncol
- Published
- 1 August 2018
- Citations
- 28
- Type
- Review
- License
- cc by-nc
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract cc by-nc
Despite the availability of potent chemotherapy regimens, such as 5-fluorouracil, folinic acid, irinotecan, and oxaliplatin (FOLFIRINOX) and nab-paclitaxel plus gemcitabine, treatment outcomes in metastatic pancreatic cancer (PC) remain unsatisfactory. The presence of an abundant fibrous stroma in PC is considered a crucial factor for its unfavorable condition. … Excerpt only: this text is the publisher’s. Read it in full at the source.